EP1135126A4 - Inhibiteurs de la kinase myt1 - Google Patents

Inhibiteurs de la kinase myt1

Info

Publication number
EP1135126A4
EP1135126A4 EP99968070A EP99968070A EP1135126A4 EP 1135126 A4 EP1135126 A4 EP 1135126A4 EP 99968070 A EP99968070 A EP 99968070A EP 99968070 A EP99968070 A EP 99968070A EP 1135126 A4 EP1135126 A4 EP 1135126A4
Authority
EP
European Patent Office
Prior art keywords
kinase inhibitors
myt1 kinase
myt1
inhibitors
kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99968070A
Other languages
German (de)
English (en)
Other versions
EP1135126A2 (fr
Inventor
Maria A Lago
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1135126A2 publication Critical patent/EP1135126A2/fr
Publication of EP1135126A4 publication Critical patent/EP1135126A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
EP99968070A 1998-12-07 1999-12-07 Inhibiteurs de la kinase myt1 Withdrawn EP1135126A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11118398P 1998-12-07 1998-12-07
US111183P 1998-12-07
PCT/US1999/028700 WO2000033837A2 (fr) 1998-12-07 1999-12-07 Inhibiteurs de la kinase myt1

Publications (2)

Publication Number Publication Date
EP1135126A2 EP1135126A2 (fr) 2001-09-26
EP1135126A4 true EP1135126A4 (fr) 2003-04-02

Family

ID=22337023

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99968070A Withdrawn EP1135126A4 (fr) 1998-12-07 1999-12-07 Inhibiteurs de la kinase myt1

Country Status (3)

Country Link
EP (1) EP1135126A4 (fr)
JP (1) JP2002531500A (fr)
WO (1) WO2000033837A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE414079T1 (de) 2000-03-01 2008-11-15 Janssen Pharmaceutica Nv 2,4-disubstituierte thiazolyl derivate
US8088806B2 (en) 2005-05-09 2012-01-03 Achillion Pharmaceuticals, Inc. Thiazole compounds and methods of use
BRPI0811939A2 (pt) 2007-05-22 2014-11-25 Achillion Pharmaceuticals Inc Tiazóis substituídos por heteroarila
EP3100742B1 (fr) * 2014-01-31 2020-05-20 Carna Biosciences Inc. Composition d'agent anticancéreux comprenant un inhibiteur cdc7 et un inhibiteur wee1
JP2023519430A (ja) * 2020-04-01 2023-05-10 リペア セラピューティクス インコーポレイテッド Ｍｙｔ１阻害剤の使用方法
WO2024084450A1 (fr) * 2022-10-21 2024-04-25 Aurigene Oncology Limited Composés hétéroaryle bicycliques et leurs dérivés en tant qu'inhibiteurs de pkmyt1
WO2024104282A1 (fr) * 2022-11-14 2024-05-23 捷思英达控股有限公司 Dérivé de 1h-pyrrolo[2,3-b]pyridine, son procédé de préparation et son utilisation en médecine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0321115B1 (fr) * 1987-12-14 1991-08-14 Sawai Pharmaceutical Co., Ltd. Carboxamides contenant un noyau tétrazole et un noyau thiazole et leur utilisation
GB9804734D0 (en) * 1998-03-05 1998-04-29 Pfizer Ltd Compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO0033837A3 *

Also Published As

Publication number Publication date
WO2000033837A2 (fr) 2000-06-15
EP1135126A2 (fr) 2001-09-26
WO2000033837A3 (fr) 2000-08-17
JP2002531500A (ja) 2002-09-24

Similar Documents

Publication Publication Date Title
EG24381A (en) Tyrosine kinase inhibitors
EP1161433A4 (fr) Inhibiteurs de tyrosine kinase
PL344477A1 (en) Pyrrole substituted 2-indolinone protein kinase inhibitors
IL148614A0 (en) Pteridinones as kinase inhibitors
IL151104A0 (en) Kinase inhibitors
IL141724A0 (en) INHIBITORS OF P38-α KINASE
IL143120A0 (en) SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
GB9900416D0 (en) Inhibitors
HK1049154A1 (zh) 作為酪氨酸激酶抑制劑的2-吡唑啉-5-酮
IL138387A0 (en) Enzyme inhibitors
AU2001241917A1 (en) Myt1 kinase inhibitors
AU3703499A (en) Substituted indolinones as kinase inhibitors
EP1153022A4 (fr) Inhibiteurs de protease
IL140243A0 (en) Fkbp inhibitors
EP1135126A4 (fr) Inhibiteurs de la kinase myt1
EP1135135A4 (fr) Inhibiteurs de la kinase chk1
GB9816358D0 (en) Enzyme inhibitors
AU1800700A (en) Ikk3 kinase
PL339940A1 (en) Myt1 kinase inhibitors
HU0001565D0 (en) Myt1 kinase inhibitors
IL135577A0 (en) Myt1 kinase inhibitors
GB9806743D0 (en) Cyclin dependent kinase inhibitors
GB9828697D0 (en) Inhibitors
GB9803416D0 (en) Inhibitors
GB9826992D0 (en) Inhibitors

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010703

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030214

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030506